UTHR

United Therapeutics Corp

$481.47

0.00 (0.00%) Today

— up— down

Compare UTHR

Market Cap

$20.65B+13.5%

Revenue (TTM)

$2.92B+2.5%

Net Income (TTM)

$1.19B+9.1%

EPS (TTM)

27.96+9.1%

Shares Out

42.45M

P/E Ratio

15.68

Forward P/E

17.29

Open

$481.47

Previous Close

$481.47

Day Range

$471.34 – $487.62

52-Week Range

$409.07 – $609.35

Beta

0.51

Volume

414.65K

Avg Volume

559.35K

Analyst Rating

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

About UTHR

United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.